AAPG · Ascentage Pharma Group International ADR
United States · RS rating 10 · As of 2026-10-14
| Price | 14.85 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 30 / 13 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 3 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +59.8% |
| Market cap (USD) | $2.1B |